| Management target | Revenue FY27 |
|---|
| Revenue growth | Lower single digit growth guided for FY27. |
|---|---|
| Margins | EBITDA margin contracted from 15.75% to 11.91% YoY. |
| Demand visibility | Impacted by monsoon timing; industry estimates modest growth. |
| Management confidence | Cautious due to industry-wide challenging first quarter. |
Growth
Revenue fell 12.56% YoY to ₹461.93 Cr; PAT dropped 34.59% to ₹36.30 Cr.
Outlook
FY27 guidance: lower single-digit revenue growth and ~200bps EBITDA margin decline. New plant operational by 2028.
Risks
Delayed monsoon, price competition, and weaker domestic demand pressured Q1 margins and volumes.
Last quarter's promises, checked
Delivered
- Guided 25% higher buyback price → delivered ₹1,400 vs ₹1,100 market (= BEAT)
- Guided FY26 inventory improvement → delivered reduced receivables by 4% (= BEAT)
- Guided Q4 volume/value growth → delivered approx 9% YoY growth (= BEAT)
Partly delivered
- Guided biostimulant revenue ₹130 Cr+ → FY26 actuals at ₹70 Cr (= PARTIAL)
Missed
- Guided Dahej FY26 revenue ₹65 Cr → delivered ₹50 Cr (= MISS)
- Guided low double-digit FY27 growth → current call pivots to low single-digit (= MISS)
- Guided EBITDA margin maintenance → current call reports 384bps YoY contraction (= MISS)
Investor Presentation filed with BSE, NSE: DHANUKA. Summary written with AI assistance from the document.
Dhanuka Agritech Ltd: key numbers
- Share price
- ₹964.35
- Market cap
- ₹4,347 Cr
- Revenue (annual)
- ₹2,020 Cr
- Net profit (annual)
- ₹287.2 Cr
- Promoter holding
- 69.81%+0.10% QoQ
- FII holding
- 1.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dhanuka Agritech Ltd
All →Dhanuka Agritech Product Launch
Dhanuka Agritech has launched 'POLIN', a new fungicide, in the domestic Indian market. This product features a novel mode of action for enhanced crop protection.
Dhanuka Agritech Credit Rating
CARE Ratings reaffirmed Dhanuka Agritech's bank facilities at 'CARE AA; Stable' and 'CARE A1+'. These ratings assess the company's financial and operational performance.
Dhanuka Agritech Employee Stock Options
Dhanuka Agritech Limited received in-principle approval from NSE and BSE to list up to 50,000 equity shares issued under its ESOP 2026 scheme.
Dhanuka Agritech Earnings Call Transcript: Key Takeaways
Revenue declined 12.56% YoY as delayed monsoons in key agricultural regions crippled herbicide demand. Management slashed guidance, projecting only single-digit growth for FY27 while facing margin pressure from high costs.
- Call
- Guides 9% growth
Dhanuka Agritech Q1 FY27 Results: Net Profit ₹36.3 Cr, Down 34.6% YoY
Dhanuka Agritech Ltd reported revenue from operations of ₹461.9 Cr (-12.6% YoY) and net profit of ₹36.3 Cr (-34.6% YoY) for Q1 FY27.
- Key figure
- Net profit ₹36.3 Cr · -34.6% YoY
Dhanuka Agritech Earnings Call: Key Takeaways
Dhanuka delivered 9% revenue growth in Q4FY26 despite challenging weather. EBITDA rose to ₹124.89cr and PAT reached ₹97.77cr, supported by a significant GST refund and improved product mix.